LinkOPH

COPENHAGEN — Dislocation and decentration remained the most common reason for IOL explantation among all lens designs studied, while glare and aberrations were the second most common, according to an annual survey.Presented by Nick Mamalis, MD, at the European Society of Cataract and Refractive Surgeons meeting, the survey details patient complaints, symptoms and reasons for explantation or intervention among five different types of foldable IOL designs: one-piece with plate, one-piece with haptics, three-piece, multifocal and accommodating.

Read more →

COPENHAGEN – At the Netherlands Institute for Innovative Ocular Surgery DMEK meeting preceding the European Society of Cataract and Refractive Surgeons meeting here, Gerrit Melles, MD, summarizes the latest advances in endothelial transplantation and talks about the early results of isolated Bowman’s layer transplantation in patients with advanced keratoconus.

Read more →

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Inducement Grants Awarded Outside the Company’s 2014 Stock Incentive Plan.

Read more →

Monthly or as-needed 0.5-mg injections of ranibizumab were effective in treating pigment epithelial detachment associated with neovascular age-related macular degeneration, according to a post hoc analysis of the HARBOR study.Visual acuity improved reg…

Read more →

Jade Therapeutics, a subsidiary of EyeGate Pharmaceuticals, received $448,185 in funding from the U.S. Army Medical Research and Materiel Command for a second year, EyeGate announced. The funding will be used to continue developing a proprietary thiolated hyaluronic acid (CMHA-S) product, which is under study for use as an ocular bandage film, and brings the total funding Jade has received from the U.S. Army’s Small Business Innovation Research program to $1.25 million, according to a press release.

Read more →